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TOOLS AND TECHNIQUES
Distinguishing aggregate formation and aggregate clearance
using cell-based assays
Evelien Eenjes1,2,*, Joanna M. Dragich1, Harm H. Kampinga2 and Ai Yamamoto1,3,‡
ABSTRACT
The accumulation of ubiquitylated proteinaceous inclusions represents
a complex process, reflecting the disequilibrium between aggregate
formation and aggregate clearance. Although decreasing aggregate
formation or augmenting aggregate clearance will ultimately lead to a
diminished aggregate burden, in terms of disease pathogenesis, the
different approaches can have distinct outcomes. Using a novel cell-
based assay that can distinguish newly formed versus preformed
inclusions, we demonstrate that two proteins previously implicated in
the autophagic clearance of expanded polyglutamine inclusions,
HspB7 and Alfy (also known as WDFY3), actually affect very distinct
cellular processes to affect aggregate burden. Using this cell-based
assay, we also establish that constitutive expression of the
aggregation-prone protein can measurably slow the elimination of
protein aggregates, given that not all aggregates appear to be available
for degradation. This new assay can therefore not only determine at
what step amodifier might influence aggregate burden, but also can be
used to provide new insights into how protein aggregates are targeted
for degradation.
KEY WORDS: Protein aggregation, Polyglutamine protein,
Chaperone, Autophagy
INTRODUCTION
The accumulation of ubiquitylated proteinaceous inclusions is a
hallmark of all adult onset neurodegenerative diseases. Although
the degree to which these intracellular structures contribute to
pathogenesis can be debated, it is clear that their accumulation is an
aberrant cellular event. In mouse models of neurodegeneration,
elimination of aggregation-prone proteins often correlates with the
amelioration of pathogenesis (reviewed in Johnson et al., 2012;
Yamamoto and Simonsen, 2010), implying that their elimination
might help to reduce toxicity. As such, genetic modifiers of protein
accumulation are often sought as potential therapeutic targets to
combat adult-onset neurodegenerative disease.
The accumulation of disease-causing proteins is a complex
process, reflecting disequilibrium between aggregate formation and
aggregate clearance. Aggregate formation begins when the local
concentration of the misfolded protein reaches a threshold to allow
for seeding and oligomerization. Next, a series of consolidation
steps ensue such that the oligomers aggregate into a larger
aggregated structure, which can then, in a microtubule-dependent
manner, evolve into a larger structure of several microns in diameter
known as an aggresome. Aggresomes can form in mitotic and
postmitotic cells; however, the classic perinuclear aggresomes that
consolidate at the microtubule-organizing center are more
commonly found in dividing cells (Kopito, 2000; Stiess et al.,
2010). Aggregate clearance can occur at different points, with the
aggregated oligomers as the most likely structure targeted for
degradation by pathways such as macroautophagy (Ravikumar
et al., 2005; Iwata et al., 2005a; Filimonenko et al., 2010).
Macroautophagy is a lysosome-mediated pathway that eliminates
cytosolic constituents that have been packaged into a transient
organelle known as an autophagosome. Although it appears
unlikely that a fully intact aggresome can be enveloped into a
single autophagosome, smaller aggregated structures up to 1 μm in
diameter have been found within these double-membraned
structures (Filimonenko et al., 2010). Earlier structures that
contribute to aggregate formation, such as misfolded monomeric
or perhaps early oligomeric states of an aggregating proteins, might
also depend on other degradative pathways, such as the proteasome
or chaperone-mediated autophagy (Mak et al., 2010; Ortega and
Lucas, 2014; Juenemann et al., 2013; Schipper-Krom et al., 2014;
Thompson et al., 2009).
Although decreasing aggregate formation or augmenting
aggregate clearance will ultimately lead to diminished aggregate
burden, in terms of disease pathogenesis, the different approaches
can have distinct outcomes. For example, if the sequestration of
misfolded and aggregation prone proteins into inclusion bodies is
an acute protective response (Arrasate et al., 2004), inhibition of
aggregate formation could promote rather than reduce toxicity,
despite decreasing aggregate burden. Conversely, whereas
promoting clearance of the misfolded monomer might slow the
rate of aggregate formation, such an intervention might not be
effective when there is a predominance of preformed aggregates and
newly formed aggregates make only a minor contribution.
Therefore, to understand fully the potential impact of an approach
on pathogenesis, it is important to distinguish experimentally at
which state aggregate burden is being affected.
Recently, two very distinct proteins have been implicated in the
macroautophagic clearance of a canonical aggregation-prone protein,
a fragment of the mutant huntingtin protein with an expanded
polyglutamine (polyQ) stretch. Overexpression of either the small
heat shock protein B7 (HspB7) (Vos et al., 2010) or the selective
macroautophagy adaptor protein Autophagy linked FYVE protein
(Alfy, also known as WDFY3) (Filimonenko et al., 2010) leads to
fewer protein aggregates and protects against toxicity in fly eye
models of polyQ toxicity, suggesting that both proteins act in the
same pathway. To explore this, we have created a novel cellular tool
that can distinguish newly formed versus preformed inclusions.
Using this model, we demonstrate that HspB7 and Alfy
overexpression actually effect very distinct cellular processes to
influence aggregate burden. Moreover, we establish that the rate ofReceived 2 September 2015; Accepted 21 January 2016
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aggregate clearance can be directly affected by the presence of newly
formed protein. This new assay can therefore not only determine at
what step a modifier might impact on aggregate burden, but can be
used to provide new insights into how protein aggregates are readied
for degradation.
RESULTS
HspB7 and AlfyC decrease the aggregation of transiently
transfected polyQ protein
HspB7 is a poorly characterized small heat-shock protein that is
expressed primarily in cardiac and skeletal muscle (Vos et al., 2009).
In a screen examining which small heat-shock proteins influence
the detergent solubility of expanded polyQ proteins, transient
overexpression of HspB7 was effective at preventing inclusion
formation and diminishing toxicity in a fly eye model of polyQ
toxicity, whereas HspB2, HspB3, HspB5 and HspB10 were not
(Vos et al., 2010). To replicate the efficacy of HspB7, we transiently
co-transfected a 17-amino-acid fragment of the huntingtin protein
(17aaHtt) carrying an expanded polyQ mutation of 103 residues
with a monomeric CFP (mCFP) tag (17aaHtt103Q–mCFP)
(Yamamoto et al., 2006) with HspB7 or control (Ctrl, empty
vector) (Fig. 1A). To measure the amount of SDS-insoluble proteins
and soluble polyQ proteins, we used a filter-trap assay (FTA)
(Fig. 1Ai,ii) and western blotting (Fig. 1Aiii,iv), respectively. As
previously shown, at 24 h post-transfection, overexpression of
HspB7 dramatically reduced the amount of insoluble polyQ protein.
Unlike previous reports that showed no effect on the SDS-soluble
fraction (Filimonenko et al., 2010), however, we found a modest but
significant increase in the presence of HspB7.
Next, we performed similar experiments with Alfy (Fig. 1B).
Alfy has been shown to be an adaptor for the selective
macroautophagy-dependent degradation of ubiquitylated
aggregates (Simonsen et al., 2004; Filimonenko et al., 2010;
Clausen et al., 2010). We have previously reported that the
overexpression of full-length Alfy or a 100-kDa C-terminal
fragment of Alfy (AlfyC), which contains all the functional
domains that are required to assist with macroautophagy, is
sufficient to increase clearance of polyQ aggregate in stably
transfected cell lines, a primary neuronal model and a transgenic fly
eye model (Filimonenko et al., 2010). Given that transiently
overexpressed polyQ proteins were not explored, we next co-
transfected AlfyC with 17aaHtt103Q–mCFP. Similar to with
HspB7, co-transfection of AlfyC decreased the SDS-insoluble
fraction of 17aaHtt103Q–mCFP (Fig. 1B). Consistent with previous
reports (Filimonenko et al., 2010), no change in SDS-soluble
protein levels was observed. These data indicate that HspB7 and
AlfyC can both diminish the amount of insoluble 17aaHtt103Q–
mCFP caused by transient transfection of this expanded polyQ
protein, whereas the SDS-soluble protein is differentially affected.
AlfyC, but not HspB7, stimulates clearance of preformed
aggregates
Although HspB7 and AlfyC affected the amount of SDS-insoluble
polyQ inclusions, co-transfection of a potential modifier with the
aggregation-prone protein makes it difficult to determine when the
modifier acts on its target. For example, as a chaperone protein,
HspB7 might interfere with aggregate formation by maintaining the
solubility of the expanded polyQ protein, or it might decrease the
levels of polyQ oligomers or aggregates by increasing their
degradation. To investigate further how HspB7 and AlfyC
impacts on insoluble polyQ protein, we used a tetracycline (tet)-
regulatable cell line stably expressing 17aaHtt103Q–mCFP or a
similar construct with 65 polyQ residues (17aaHtt65Q–mCFP)
(Fig. S1) (Yamamoto et al., 2006). Similar to in disease conditions,
these cell lines demonstrate a steady state level of preformed
inclusions when maintained in the ‘tet-on’ state, in which 30 to 40%
of the cells are positive for aggregates. To eliminate expression, cells
are exposed to doxycycline (dox), upon which clearance of
aggregates is revealed. Thus, for these experiments, the polyQ-
Fig. 1. Overexpression of HspB7 or Alfy leads to a decreased amount of
insoluble polyQ protein when 17aaHtt103Q–mCFP is transiently
transfected. HeLa cells were co-transfected with 17aaHtt103Q–mCFP and
either HspB7 (A) or a FLAG tagged C-terminal (2461–3526) construct of Alfy
(AlfyC) (B). Samples were prepared at 24 h post-transfection. Samples were
analyzed for detergent insoluble protein using a FTA (i,ii). Each sample is
slotted across a threefold dilution from high to low, as denoted by the triangle.
The densitometry measurement of the highest concentration is quantified.
Soluble protein levels and sample loading was confirmed by immunoblotting
(iii,iv). 17aaHtt103Q–mCFP protein is probed with anti-GFP antibody. Vinculin
is used as a loading control for densitometry quantification. (A) HspB7 co-
expression. (i,ii) Quantification of FTA reveals that HspB7 overexpression
significantly decreases levels of detergent insoluble 17aaHtt103Q–mCFP
protein with 103Q [F(1,4)=46.989; *P=0.0024]. (iii,iv) Western blot analysis also
revealed overexpression of HspB7 leads to a small increase of SDS-soluble
polyQ protein [F(1,4)=16.685; *P=0.0150]. (B) AlfyC co-expression. (i,ii) FTA
reveals that AlfyC co-expression leads to a significant decrease in the amount
of detergent insoluble 103Q protein [F(1, 4)=61.670; *P=0.0014]. (iii,iv)
Immunoblotting reveals that AlfyC has no effect on the amount of SDS-soluble
polyQ protein [F(1,4)=0.061; P=0.8172]. Data represented as mean+s.d. from
n=3 independent experiments. Two-tailed ANOVAs were performed to
determine statistical significance. Ctrl, empty vector.
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expressing cells were maintained continuously without dox, to
maintain the presence of preformed aggregates. First, we
overexpressed AlfyC in these cell lines. Similar to in conditions
of transient expression, 72 h of AlfyC overexpression decreased the
amount of insoluble polyQ protein under conditions of stable polyQ
expression (Fig. 2Ai,ii). Levels of SDS-soluble 17aaHtt65Q were
unaffected by AlfyC overexpression, consistent with Alfy being an
adaptor for aggregated proteins (Fig. 2Aiii,iv).
We next determined whether HspB7 could reduce the levels of
insoluble polyQ proteins under these conditions (Fig. 2B). Despite
the robust response we observed in Fig. 1A, overexpression of
HspB7 had no effect on either the SDS-soluble or -insoluble pool of
polyQ protein in cells stably expressing 17aaHtt65Q–mCFP
(Fig. 2Bi–iv) or 17aaHtt103Q–mCFP (Fig. S1). To confirm our
findings, we also counted the number of CFP-positive inclusions per
cell, which also showed no difference between HspB7 and control
transfections (Fig. 2Bv,vi; Fig. S1C). These data indicate that unlike
AlfyC, HspB7 cannot eliminate preformed polyQ inclusions,
suggesting that these two proteins act in different pathways to
affect the aggregate burden in cells.
Clearance of accumulated protein in inducible cell line
expressing HaloTag-fused polyQ
Our findings represented in Figs 1 and 2 give rise to the question,
when does HspB7 or Alfy exert its effect on aggregation? Bymerely
relying on a single fluorophore tag, we are prevented from
temporally distinguishing the aggregation events occurring in the
cells. Thus, to permit the study of polyQ aggregation over time, we
Fig. 2. Overexpression of AlfyC but not HspB7 leads to a decrease in the amount of preformed 17aaHtt65Q aggregates in a stably expressing polyQ cell
line. (A) AlfyC was transfected into a stable cell line expressing 17aaHtt65Q–mCFP. The stable cell lines are maintained in the absence of dox, and are
thus under continuous expression. Samples for FTA (i,ii) and western blotting (iii,iv) were prepared at 72 h post-transfection (n=3). AlfyC diminishes the
amount of detergent-insoluble aggregated protein [F(1, 4)=55.902; *P=0.0017] (i,ii); however it has no effect on SDS-soluble 17aaHtt65Q [F(1 ,4)=0.063;P=0.8137]
(iii,iv). (B) HspB7 was transfected under the same conditions as A, and samples were prepared for FTA (i,ii) after 24 (n=4), 48 (n=4) or 72 (n=3) hours post-
transfection, and western blot analysis (iii,iv) after 24 (n=3), 48 (n=3) or 72 (n=2) hours post-transfection. Both show that HspB7 has no effect on the amount of
SDS-insoluble [F(1, 16)=0.539; P=0.4734] or SDS soluble [F(1,10)=0.670; P=0.4321] 17aaHtt65Q–mCFP protein. Western blotting also shows that HspB7 protein
decreased in levels within 72 h after transfection. (v,vi) Image-based analysis also reveals that HspB7 does not influence the percentage of cells with
17aaHtt103Q–mCFP aggregates (green) [F(1, 6)=0.366; P=0.5672]. Nuclei are stained with Hoechst 33342 (blue). 100 cells were counted per experimental
replicate (n=2). Data represented as mean+s.d. from the number of independent experiments indicated above. Scale bars: 10 μm. Two-tailed ANOVAs were
performed to determine statistical significance. Ctrl, empty vector.
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created an inducible stable cell line expressing an exon 1 fragment
of Htt with 103 polyQ residues (exon1htt103Q) tagged with
HaloTag (exon1Htt103Q–HaloTag) (Fig. 3). HaloTag-fused
proteins can be irreversibly labeled with fluorescent dyes such as
tetramethylrhodamine (TMR), Oregon Green or coumarin that have
been covalently linked to a haloalkane component (Los et al.,
2008). Given that ligand binding is irreversible, different fluorescent
ligands can be used to pulse-label and study aggregation over time
(Fig. S2A). To offer further experimental flexibility, we also used a
tet-regulatable design (Fig. S2B) to permit comparison with existing
single fluorophore cell lines, such as the 17aaHtt103Q–mCFP used
in Fig. 2.
We have previously found that in our tet-regulatable cells stably
expressing 17aaHttpolyQ–mCFP shutting off gene expression using
dox leads to aggregate clearance in 3 to 5 days (Fig. S1) (Yamamoto
et al., 2006). To ensure that the HaloTag tag did not affect
aggregation or clearance, we examined tet-regulatable aggregate
clearance in the exon1Htt103Q–HaloTag cells (Fig. 3). First, to
ensure that HaloTag did not affect aggregation, cells were
maintained in the gene-on state (i.e. no dox) for several passages,
then exposed to TMR.We found that TMR-positive aggregates were
recognized by the EM48 antibody, indicating that they were specific
for the exon1Htt103Q protein (Fig. 3A). Next, using the HaloTag,
we examined aggregate clearance with TMR and Oregon Green to
label the different populations of exon1Htt103Q (Fig. 3B). Initially,
prior to dox administration, TMR was added to label all of the
existing exon1Htt103Q present before shutting off gene expression.
Next, dox was administered to shut off exon1Htt103Q expression.
After 0 to 96 h and, prior to fixation, Oregon Green was used to label
any exon1Htt103Q that might have been newly expressed after dox
treatment. Oregon-Green-positive protein would therefore be
indicative of any significant leakiness of the tet-regulation.
Image-based analysis at time 0 h revealed that TMR efficiently
labeled aggregate-like structures (Fig. 3B,C). At steady state, 40 to
50% of cells contained TMR-positive aggregates, but none were
positive for Oregon Green (Fig. 3C,D), indicating that the
concentration of TMR used fully occupied the available HaloTag-
binding sites. Further analyses of TMR or Oregon Green staining
revealed that, similar to with the 17aaHttpolyQ–mCFP cell lines,
exposure to dox led to a decrease in the number of cells with
aggregates over time. All TMR-positive aggregates were eliminated
after 72 h of dox, although a substantial decrease occurred within
48 h (Fig. 3C,D). When examining for Oregon Green staining, there
were no aggregates positive for Oregon Green, indicating that there
was no detectable leakiness of exon1Htt103Q–HaloTag expression
after dox treatment (Fig. 3C,D).
FTA and immunoblotting analyses against the HaloTag tag also
showed that under similar conditions, there were no longer
Fig. 3. The inducible Exon1Htt103Q–HaloTag cell line demonstrates aggregate clearance upon dox administration. (A) EM48 immunofluorescence
(green) confirms that the TMR-positive aggregates (red) represent aggregated exon1Htt103Q–HaloTag. Nuclei are stained with Hoechst 33342 (blue). (B) Time
line outlining experimental design. Stable cell lines are maintained in the ‘on’ state. At time 0, cells are exposed to 0.5 μM TMR for 30 min, and then doxycycline
(dox). Prior to analysis (0 h), and at 24, 48, 72 and 96 h later, cells are exposed to 1.5mMOregonGreen (OG) for 30min to label the newly formed exon1Htt103Q–
HaloTag protein. (C,D) Representative images (C) and quantification (D) at time 0, 48 and 96 h after treatment with 1 μg/ml of dox. Examining the TMR (red)
and Oregon Green (green) channel reveals no detectable Oregon Green staining. Quantification of all of the aggregates detected in both channels reveals that
when expression is abolished, aggregates are no longer detectable after 72 h. Very little detectable Oregon-Green-positive structures are found, and the TMR-
positive aggregates are primarily cleared. Data represented as mean+s.d. from n=4 independent experiments. An average of 1000 cells per time point was
counted. Scale bars: 10 μm.
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detectable levels of SDS-insoluble and soluble exon1Htt103Q–
HaloTag protein after 48 h and 24 h, respectively (Fig. 4A).
Lysosomal inhibition using 10 μM chloroquine (Chlor)
significantly impeded the clearance of the insoluble polyQ but
not of soluble polyQ protein (Fig. 4B), suggesting that only the
aggregates were being degraded by macroautophagy, consistent
with the data collected from mCFP-tagged cells lines (Yamamoto
et al., 2006; Filimonenko et al., 2010). To determine whether
exon1Htt103Q–HaloTag colocalizes to autophagosomes, we next
examined primary cortical neurons generated from mice
expressing a GFP-tagged form of the mammalian homolog of
Atg8, MAP1 light chain 3B (LC3, also known as MAP1LC3B)
(Mizushima et al., 2004), an autophagosome marker (Kabeya
et al., 2000). Primary cortical neurons were transiently transfected
with exon1Htt103Q–HaloTag and then exposed to TMR.
Confocal microscopy revealed that TMR-positive structures
colocalized to GFP–LC3 positive structures (Fig. 4C). In
summary, these data indicate that the exon1Htt103Q–HaloTag
can be used to monitor the formation and clearance of aggregated
polyQ proteins.
HaloTag tracks the formation and clearance of aggregates
over time
Although using the tet-regulatable system in different systems has
revealed that mitotic and postmitotic cells have the innate capacity
to eliminate protein aggregates (Filimonenko et al., 2010;
Yamamoto et al., 2006, 2000), it remains uncertain whether
aggregate clearance can still occur under conditions of continuous
expression. This apparent subtlety is relevant because it more
accurately reflects the physiological conditions under which
aggregate clearance would be occurring. It is plausible that under
continuous expression, seeded aggregates would continue to
evolve, owing to the continuous addition of newly forming
oligomers. In this model, growing aggregates might not be
properly targeted and/or trafficked for degradation. Additionally,
the study of aggregate clearance in dividing cells can be further
Fig. 4. The exon1HTT103Q–HaloTag aggregates are
cleared in a lysosome-dependent manner. (A) FTA (i,ii)
andwestern blotting (iii,iv) were used to study the clearance
of exon1Htt103Q–Halotag (103Q-HT or HT) protein.
Membranes were probed with an anti-HaloTag antibody.
(i,ii) Detergent-insoluble exon1Htt103Q–HaloTag protein
could no longer be detected after 48 h. Based on Fig. 3, this
suggests that image-based analysis might be more
sensitive for analysis of clearance in this cell line. (iii,iv)
Western blot analysis shows that detergent-soluble protein
is cleared within 24 h. (B) Exon1Htt103Q–HaloTag cells
were exposed to 1 µg/ml dox without or with 10 µM of the
lysosome inhibitor chloroquine (Chlor) for 48 h. Samples
were analyzed by FTA (i,ii) or western blotting (iii). The
presence of Chlor significantly impedes the clearance of
the detergent insoluble protein [F(2, 6)=214.395,
*P=0.0015]. Lysosomal inhibition did not retard the
clearance of soluble exon1Htt103Q protein [F(2, 6)=
2578.875, P=0.8616]. The accumulation of LC3 II (the
lipidated form of LC3) signifies diminished autophagosome
maturation, confirming lysosome inhibition. (C)
Exon1Htt103Q–HaloTag colocalizes with GFP–LC3 in
primary neurons. Primary cortical neurons generated from
GFP–LC3 transgenic mice were transiently transfected
with exon1Htt103Q–HaloTag, and exposed to TMR 24 h
later. Data represented as mean+s.d. from n=3
independent experiments. Scale bar: 10 μm. Two-tailed
ANOVAs were performed to determine statistical
significance.
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confounded by cytoplasmic dilution and asymmetric segregation
(Rujano et al., 2006). Although the HaloTag will not necessarily
eliminate the impact of dilution or segregation, unlike using a single
fluorophore tag, a single population of aggregates can be tracked
over time, despite the addition of new protein, thus making the
confounds due to cell division less invisible. Therefore, we next
used the exon1Htt103Q–HaloTag cell line to determine whether
aggregates are degraded during constitutive expression of the polyQ
protein (Fig. 5).
To differentially label the pools of exon1Htt103Q, TMR and
Oregon Green were used at different times. Similar to Fig. 3, cells
were allowed to attain steady state under tet-on conditions. At time
0, cells were exposed to TMR to label all of the pre-existing protein.
Next, to label the subsequently formed protein and aggregates, cells
were labeled with Oregon Green 0, 24, 48, 72 or 96 h later, and then
collected for analyses (Fig. 5A). First, TMR-positive versus the
Oregon-Green-positive staining was examined. At time 0, similar
to in Fig. 3D, there were many TMR-positive structures, but no
Oregon-Green-only aggregates present (Fig. 5B). As time
progressed, the number of TMR-positive aggregates decreased
as the number of Oregon-Green-positive aggregates increased
(Fig. 5C,D). These data indicate that aggregate clearance occurs
despite continuous expression of exon1Htt103Q–HaloTag, and that
clearance occurred in the background of new aggregates being
formed. Furthermore, the rate at which the number of Oregon-
Green-positive aggregates grew between 24 and 48 h (from 6±5%
to 40±13%) compared to that at which the number TMR-positive
aggregates fell (44±17% to 28±9%; mean±s.d. from n=4
independent experiments) suggests that the rate at which
aggregates form is greater than the rate at which they are cleared.
Finally, even after 96 h, the number of TMR-positive aggregates did
not fully decline, indicating that although clearance can occur,
TMR-positive structures persist much longer under constitutive
expression of mutant protein than when mutant protein expression is
eliminated after aggregate formation.
The analyses performed thus far examined the TMR-staining
and Oregon Green staining independently of each other. As shown
in Fig. 5C, the addition of Oregon Green after TMR can lead to
the formation of aggregates that are positive for both ligands.
This colocalization indicates the incorporation of newly formed
Oregon-Green-positive protein into the pre-existing TMR-positive
aggregates. This was confirmed by confocal analysis. When TMR
was added 24 h after another HaloTag-ligand coumarin, coumarin-
positive aggregates can be found surrounded by TMR-positive ones
(Fig. 5E). Similar results can be seen with other HaloTag-ligand
combinations (data not shown).
We next re-analyzed the data for TMR-only, Oregon Green-only,
and TMR and Oregon Green double-positive aggregates. In the
presence of dox, re-analysis had little impact, given that no
substantial levels of mutant protein were being newly created
(Fig. S3A). In contrast, under conditions of constitutive expression,
segregating the TMR and Oregon Green double-positive aggregates
revealed that TMR-only aggregates were eliminated within 72 h
(Fig. 5F), which is similar to the rate observed in the presence of dox
(Fig. 3D). Unlike dox-treatment, however, many of the TMR-only
structures evolved into TMR and Oregon Green double-positive
aggregates, indicating that addition of newly formed Oregon-Green-
positive protein onto pre-existing TMR-positive aggregates
accounts for the diminished clearance observed in Fig. 5D. The
sum of TMR-only, TMR and Oregon Green double-positive, and
Oregon Green-only aggregates were the same across all time points,
confirming that the system had reached steady state (Fig. S3B).
These data signify that in order to be degraded, aggregates must
reach a state at which they no longer can incorporate newly
synthesized protein. Analysis of the Oregon-Green-only structures
revealed that aggregates can form de novo in the background of
aggregate clearance and aggregate growth; however, during the time
at which preformed inclusions are present, consolidation of newly
formed protein into pre-existing aggregates is dominant to the
formation of new ones. In summary, our analyses reveal that by
using HaloTag to temporally label the aggregation-prone proteins,
we can distinguish how aggregation evolves in the cell, and at what
stage these structures can finally be eliminated.
HspB7 affects aggregate formation and AlfyC affects
aggregate clearance
Having established our exon1Htt103Q–HaloTag cell line, we
returned to HspB7 and AlfyC to test the hypothesis that HspB7
interferes with aggregate formation whereas AlfyC affects aggregate
clearance (Fig. 6). We first examined the overexpression of HspB7
(Fig. 6A–C). HspB7 was transfected into exon1Htt103Q–HaloTag
cells that were labeled with TMR to label the existing protein and
aggregates. At 72 h post-transfection, cells were labeled with
Oregon Green, then fixed and analyzed. Confirming our findings in
17aaHttpolyQ–mCFP cells (Fig. 2), HspB7 overexpression had no
effect on the total number of aggregates (Fig. 6B). When broken
down by ligand, HspB7 had no effect on TMR-only structures, no
effect on TMR and Oregon Green double-positive structures but a
significant effect on Oregon-Green-only structures. These data
indicate that once an aggregate forms, HspB7 has little impact on
its turnover (TMR-only), and cannot disrupt the further
oligomerization of aggregates (both TMR and Oregon Green). By
contrast, HspB7 reduced de novo formation of aggregates as
revealed by the reduction of Oregon-Green-only structures.
Nonetheless, they are but a small percentage of the total
aggregates present (Fig. 6C), and thus there was little impact on
the total aggregate population. This is consistent with what has been
reported previously (Vos et al., 2010) and what we find here, that is,
co-transfection of HspB7 with the aggregation-prone protein leads
to a dramatic impact on aggregation by affecting the formation of
SDS-insoluble inclusions. Although HspB7 continues to exert its
function in Fig. 2, its effect is masked by the fact that very few
aggregates are formed de novo in the presence of preformed
inclusions. By using the HaloTag, this distinction could be
observed.
We next examined the effect of AlfyC using the same protocol
outlined above (Fig. 6D–F). Overexpression of AlfyC significantly
decreased the total number of aggregates, and does so by decreasing
TMR-only preformed inclusions and modestly reducing Oregon-
Green-only inclusions. Interestingly, the overexpression of Alfy had
no effect on the total number of TMR and Oregon Green double-
positive structures. Taken together with Fig. 5, these data suggest
that AlfyC can recognize protein aggregates that are preformed or
newly formed and target them for degradation; however, aggregates
that also contain newly formed proteins are somehow not available
for Alfy-mediated targeting, thus limiting the efficacy of Alfy.
Although it is possible that smaller, discrete TMR-only or Oregon-
Green-only structures within the TMR and Oregon Green double-
positive aggregates are being targeted for degradation, the efficiency
is not such that the total number of TMR Oregon Green double-
positive structures is diminished. Given that this latter pool of
double-positive structures represent the clear majority of aggregates,
identifying modifiers that affect this pool might have the greatest
impact on aggregate burden.
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Fig. 5. Exon1Htt103Q–HaloTag cell lines can be used to monitor aggregate formation, growth and clearance under the continuous presence of polyQ
protein. (A) Schematic of the experiment design. Cells were exposed to 0.5 μM TMR (red) for 30 min. Prior to collection at the times indicated, cells were also
exposed to Oregon Green (OG, green) for 30 min. (B–D) Representative images [at 0 h (B), 24, 48, 72 and 96 h (C)] and quantification (D) of TMR- or Oregon
Green-positive aggregates. Areas highlighted in the white box are shown at higher magnification below the respective image. Cells reveal that aggregate
clearance can occur during continuous expression of exon1Htt103Q–HaloTag. At 0 h all aggregates are TMR-positive with little to no detectable Oregon-Green-
positive structures. As time progresses, there is a gradual shift such that after 96 h most of the TMR-positive aggregates are cleared and are positive for
Oregon Green. (E,F) Under conditions of continuous expression, aggregates can be positive for two different HaloTag ligands. (E) Representative image of a
coumarin-positive aggregate, which continued to grow to incorporate new TMR-positive exon1Htt103Q–HaloTag protein. 24 h after coumarin, TMR was
administered to label this newly expressed protein. (F) Re-analysis of the data represented in D to include TMR-only, TMR andOregonGreen double-positive and
Oregon-Green-only aggregates reveals that TMR-only aggregates are short lived and are either cleared or continue to further incorporate protein. By 96 h, most of
the TMR-containing aggregates are eliminated and become mostly only positive for Oregon Green. Nuclei are stained with Hoechst 33342 (blue). Data
represented as mean±s.d. from n=4 independent experiments. An average of 1000 cells per time point was counted. Scale bars: 10 μm.
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The aberrant accumulation of aggregated proteins and their potential
link to toxicity makes identifying modifiers of protein accumulation
an attractive therapeutic target. Furthermore, understanding how
these modifiers exert their mechanism of action is likely to be more
beneficial than simply measuring aggregate load as a final outcome.
By using irreversible labeling with a variety of fluorophore-based
HaloTag ligands, we have been able to gain a greater understanding
of the accumulation of a class of aggregation-prone proteins. We
have found that preformed inclusions are degraded both in the
Fig. 6. HspB7 suppresses the formation of new aggregates, whereas AlfyC stimulates the clearance of aggregates that are no longer growing.
Exon1Htt103Q–HaloTag cells were transfected with HspB7 or AlfyC with their respective Ctrl (empty vector). After exchanging the transfection medium, cells
were exposed to TMR (red) to label pre-existing protein. After 48 to 72 h, Oregon Green (OG) was added to label newly expressed proteins, then cells were
analyzed for TMR-only, TMR and Oregon Green double-positive and Oregon-Green-only positive structures. Nuclei are stained with Hoechst 33342 (blue).
(A–C) HspB7-transfected cells. (A) Representative images 48 h after Ctrl or HspB7 transfection. Areas highlighted in the white boxes are shown at higher
magnification below the respective image. (B) Quantification of TMR-only, Oregon Green double-positive and Oregon-Green-only aggregates normalized to Ctrl.
Similar to in Fig. 2B, HspB7 does not decrease the total number of aggregates [F(1,10)=0.024; P=0.8800], because HspB7 does not affect the number of pre-
existing (TMR-only) and growing (TMR andOregonGreen) aggregates [F(1,10)=4.224;P=0.697 and F(1,10)=1,149;P=3.090, respectively]. HspB7 overexpression,
however, leads to a significant decrease of Oregon-Green-only aggregates [F(1,10)=12.247; *P=0.0057], indicating that HspB7 affects the formation of new
aggregates. (C) Graphical representation of how the different aggregate stages are represented in the total number. Consistent with Fig. 5, the majority of the
aggregates are TMR and Oregon Green double-positive, followed by TMR-only then Oregon Green-only. Therefore, despite the impact HspB7 had on Oregon-
Green-only aggregates, there was not a significant impact on the total number of aggregates present. (D–F) AlfyC-transfected cells. (D) Representative images
72 h after Ctrl or AlfyC transfection. (E) Quantification of TMR-only, TMR and Oregon Green double-positive and Oregon-Green-only aggregates normalized to
Ctrl. Similar to in Fig. 2A, AlfyC decreases the total number of aggregates [F(1,10)=32.595; P=0.0002]. This decrease is due to a significant decrease in TMR-only
and Oregon-Green-only aggregates [F(1,10)=71.548; P<0.0001 and F(1,10)=11.111; P=0.0076, respectively]. There was no impact on the TMR and Oregon Green
double-positive growing aggregates in the presence of AlfyC [F(1,10)=2.054; P=0.1823]. (F) Graphical representation of how the different aggregate stages are
represented within the total number of aggregates. Data are represented as mean+s.d. from n=6 independent experiments. An average of 750 cells per time point
was counted. Scale bars: 10 μm. Two-tailed ANOVAs were performed to determine statistical significance. n.s., not statistically significant.
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presence and absence of newly synthesized protein, and that
aggregates must reach a degradation-competent state to be targeted
for elimination. Moreover, by examining the influence of two
proteins previously described to inhibit protein accumulation
similarly, we have been able to demonstrate that comparable
outcomes can be reached by affecting discrete stages of protein
accumulation and clearance.
This study highlights several points. First, we introduce a novel
method by which we can distinguish how a given pathway or
modifier affects protein accumulation. Different degradation
pathways have been implicated in affecting the accumulation of
aggregation-prone proteins, from proteasome-mediated degradation
(Mishra et al., 2008; Iwata et al., 2009; Zhang et al., 2010;
Urushitani et al., 2010; Ortega and Lucas, 2014; Schipper-Krom
et al., 2014) to the lysosome-mediated pathway or macroautophagy
as being the predominant pathway for aggregate clearance
(Ravikumar et al., 2002; Iwata et al., 2005b; Yamamoto et al.,
2006; Pankiv et al., 2007; Lamark et al., 2009; Fan et al., 2010;
Lamark and Johansen, 2012; Odagiri et al., 2012; Castillo et al.,
2014; Bae et al., 2014). Our ability to interrogate how each pathway
might contribute to aggregate turnover has been limited by our
inability to temporally characterize aggregate formation and
clearance in cells. For example, although several studies indicate
that macroautophagy eliminates aggregated proteins, the underlying
molecular mechanism remains unclear. Currently, several
molecular scaffolding proteins have been implicated in the
process (Mijaljica et al., 2012; Lamark and Johansen, 2012;
Rogov et al., 2014). We find that the molecular scaffold Alfy, which
bridges the ubiquitylated protein with the core machinery involved
in autophagosome formation (Filimonenko et al., 2010), targets
aggregated structures for degradation rather than the detergent-
soluble form. Moreover, the aggregates that can be targeted must be
static and inert to newly synthesized aggregating proteins. Using a
similar approach, the impact of the other implicated scaffolds, such
as p62 (also known as SQSTM1) (Pankiv et al., 2007), NBR1
(Kirkin et al., 2009) and others (Korac et al., 2013; Rogov et al.,
2014), can be examined with our newly created assay, to establish
temporally when these scaffolds influence clearance. Further study
might also determine how an aggregate transitions from a
degradation-competent, TMR-only state to a TMR and Oregon
Green double-positive state. One weakness of our approach,
however, is that it is currently difficult to achieve sub-saturation
levels of fluorescent intensity of a given dye, thus the actual
amounts of protein rather than number of aggregated structures is
difficult to interpret. The development of a dark HaloTag dyewould
help to dilute the amount of fluorescent dye used without affecting
our ability to fully occupy the binding sites in the HaloTag.
Nonetheless, our findings strongly suggest that even simply
examining the number of structures transitioning between the two
aggregated states might lead to strategies that will hasten the
clearance of these otherwise persistent structures.
Next, our data revealed that even the most robust modifiers of
aggregate formation can have a minimal effect on preformed
inclusions. Of all the small heat-shock proteins examined, HspB7
was the most potent inhibitor of aggregation (Vos et al., 2010).
Despite this, we found that in the presence of preformed inclusions,
the ability of HspB7 to reduce aggregate load is minimal. Our
findings suggest that HspB7 prevents the de novo formation of
aggregates, but once preformed inclusions are present, newly
formed aggregates make a relatively small contribution to total
aggregate load, and thus the impact of HspB7 is lost. Although
HspB7 affected a pre-aggregated structure, surprisingly, the
chaperone did not prevent aggregate growth. This implies that
HspB7 either affects newly formed aggregates by preventing the
seeding event, or cannot sufficiently inhibit aggregate growth
because the rate of oligomer incorporation is too great.
In summary, the final outcome of aggregate load is the sum of a
complex series of discrete cellular events that can be differentially
affected by modifiers. Although the ultimate goal of therapeutic
approaches to treat neurodegeneration may be to diminish the
abnormal accumulation of ubiquitylated proteins, simply focusing
on this final outcomemight mask themechanism bywhich aggregate
load is affected, which in turn might lead to disappointing outcomes
when tested under physiological conditions. To overcome these
limitations, we created an inducible stable cell line that temporally
labels the aggregating protein to expose how a modifier influences
aggregate load, and revealed that themechanism of action, and hence
therapeutic potential, of two apparently similarly acting proteins
were quite distinct. Moreover, this assay revealed that the growing
aggregate pool represents the majority of aggregates under
conditions where aggregates are already present, thus leading to
the prediction that identification of modifiers that prevent aggregates
from incorporated newly formed proteins will have the greatest
impact on aggregate burden and thus disease progression.
MATERIALS AND METHODS
Antibodies
The following antibodies were used for immunoblotting and/or FTA: rabbit
anti-FLAG [polyclonal, 1:400 (2.5 µg/ml); Sigma]; mouse anti-GFP
(polyclonal, 1:1000; Roche); chicken anti-GFP (1:1000; Abcam); rabbit
anti-HaloTag (1:500; Promega); mouse anti-HspB7 (1:500; Abnova); rabbit
anti-LC3B (ab48394, 1:1000; Abcam); and rabbit anti-vinculin (1:5000;
Life Technologies). Mouse anti-EM48 (1:100; EMD Millipore, Billerica,
MA) was used for immunofluorescence.
Plasmids
HspB7 and AlfyC constructs were created as previously described
(Filimonenko et al., 2010; Vos et al., 2010). The Exon1htt103Q construct
with alternating CAGCAA repeats was received from Alexei Kazantsev
(MassGeneral Institute for Neurodegenerative Disease, Massachusetts
General Hospital, USA) (Kazantsev et al., 1999). Exon1htt103Q–
HaloTag construct was created by subcloning Exon1Htt103Q into pHT2
(Promega) using the restriction enzymes NheI and BamHI. This was
subsequently subcloned into the NheI/NaeI sites in the pBi4 TetO inducible
vector (Baron et al., 1995).
Cell culture
HeLa cell cultures were maintained in high-glucose Dulbecco’s modified
eagle medium (DMEM; Life Technologies) supplemented with 10% fetal
bovine serum (FBS; Life Technologies) at 37°C and in a 5% CO2-
containing atmosphere. 17aaHtt-polyQ–mCFP cell lines were maintained
using 100 μg/ml of hygromycin (Life Technologies) and 50 μg ml−1 of
G418 (Life Technologies) as described previously (Yamamoto et al., 2006).
Lysosome inhibition was achieved using chloroquine (Chlor) (10 μM,
Sigma). All cell lines were confirmed by PCR to be negative for mycoplasm,
and are grown in the absence of penicillin and streptomycin.
Transfection
Cells were plated in a 6- or 24-wells plate and transfected 24 h later with
AlfyC or HspB7 plasmid DNA alone using Lipofectamine (Life
Technologies) or co-transfected with 17aaHtt65Q–mCFP or 17aaHtt103Q–
mCFP using Lipofectamine 2000 (Life Technologies) according to the
manufacturer’s protocol. Single plasmid transfections were conducted with
1.0 μg of plasmid DNA in six-well plates and 0.3 μg of plasmid DNA in 24-
well plates. Co-transfections were performed using 0.5 μg of 17aaHtt103Q–
mCFP and 1.0 μg HspB7 or AlfyC plasmid DNA. Cells were incubated with
transfection medium for 5 h then changed into DMEM with 10% FBS
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overnight. Cells were collected and analyzed as described in the respective
figure legends. Briefly, for image-based analyses, cells were plated onto
coverslips, treated as described, then mounted with ProLong Antifade
Gold with DAPI (Molecular Probes).
Primary neurons
The use of GFP–LC3-expressing mice (Mizushima et al., 2004) complied
with the Guide for Care and Use of Laboratory Animals and were approved
by the IACUC committee at Columbia University. Mice were maintained in
a 12-h-light–12-h-dark cycle in a temperature and humidity controlled
environment, with ad libitum access to food and water. GFP–LC3-
expressing mice (C57BL/6) were maintained as homozygous and
genotyped as described previously (Kuma and Mizushima, 2008).
Primary dissociated cortical cultures were prepared from postnatal day 0
(P0) pups. The cortical lobes were dissected in ice cold DMEM/F12 (Life
Technologies) containing 10% heat-inactivated FBS and trypsinized for
30 min at 37°C, then triturated in fresh 10% FBSDMEM/F12 through a fire-
polished glass pipette and filtered through a 40-μm nylon cell strainer. For
transient transfection, cells were plated at a density of 1.0×106 cells/well
onto coverslips coated with 20 μg/ml poly D-lysine (Sigma) and 5 µg/ml
mouse laminin (Life Technologies). The medium was changed 2 h after
plating to Neurobasal medium (Life Technologies) containing 0.5 mM
L-glutamine, 1× B27 supplement (Life Technologies), 2% heat-inactivated
FBS and 1× antibiotic (Life Technologies). 1.5 μM coumarin HaloTag
ligand (Promega) was added to the medium 24 h post-transfection for 1 h,
followed by a complete change in medium. After 24 h 500 nM TMR
HaloTag ligand (Promega) was added for 30 min and cells were fixed in 4%
paraformaldehyde in PBS and mounted under coverslips with Prolong
Antifade Gold (Life Technologies).
The exon1Htt103Q–HaloTag inducible cell line was created from the
polyQ–HaloTag cell line using methods previously described (Cremona
et al., 2011; Yamamoto et al., 2006). Briefly, pBi4-exon1Htt103Q-HT was
co-transfected at a 1:10 ratio with Ptk-hygro into tTA-positive HeLa cells
(Clontech). Selection of clones was achieved by using 800 µg ml−1
hygromycin. tTA-positive cells were maintained in medium that contained
50 µg ml−1 G418. A concentration of 1 μg/ml dox was sufficient to shut
off production of new exon1Htt103Q–HaloTag protein. This cell line was
maintained by culturing in the presence of 100 μg ml−1 of hygromycin
and 50 μg ml−1 of G418. 500 nM TMR HaloTag ligand (Promega) or
1.5 μM Oregon Green HaloTag ligand (Promega) was incubated with
the cells for 30 min at 37°C, followed by three washes with culture
medium at the time points shown. For the experiments performed
in Fig. 6, protein was labeled with TMR following a 5-h incubation in
transfection medium.
Western blotting and FTA
Sample preparation
Cells were washed with PBS, trypsinized and pelleted. Cells were lysed in
1% PBS with Triton X-100 containing 8 M Urea, 5 mM EDTA, 100 mM
NaCl and 50 mM Tris-HCl, and incubated on ice for 20 min. 1× protease/
phosphatase inhibitor cocktail (Thermo Fisher Scientific) was freshly added
each time to the lysis buffer. Transiently transfected polyQ samples were
centrifuged at 2655 g, whereas stably expressing polyQ samples were
centrifuged at 20,817 g. Samples were centrifuged in an Eppendorf 5417R at
4°C. Pellets were discarded and supernatants were used for both western
blotting and filter trap assay. Protein concentrations of the supernatant
fractions were determined by the DC protein assay reagent (Bio-Rad,
Hercules, CA) and equal concentrations of protein were eluted in 4× LDS
sample buffer (Life Technologies) and 50 mM 1,4-dithiothreitol (DTT,
Sigma). Samples were processed for both FTA and western blot analysis to
prevent extended exposure to urea.
Western blot analysis
20 μg of protein was boiled for 5 min and loaded on a 4–12%NuPAGE Bis-
Tris gel (Life Technologies), and transferred onto PVDF membranes with a
0.2 μm pore size (Life Technologies). The blots were blocked for 1 h in PBS
containing 1% Tween-20 and 3% BSA at room temperature, and probed
overnight with primary antibodies at 4°C. Next day, membranes were
washed three times with PBS containing 1% Tween-20 and incubated for
1 h with horseradish peroxidase (HRP)-conjugated secondary antibodies
(Thermo Fisher Scientific) at a dilution of 1:5000 to 1:10,000. Signal was
detected with SuperSignal WestDura Substrates (Thermo Fisher Scientific).
Blots were developed using the VersaDoc Imaging system (Bio-Rad). The
intensities of the different bands were measured using the software provided
by the VersaDoc Imaging system.
Filter trap assay
Either three- or five-fold dilutions of protein was prepared and slotted onto a
pre-washed (PBS 0.1% SDS) 0.2 μM cellulose acetate membrane (0.2 μM
pore size, GE Healthcare Life Sciences, Marlborough, MA) using a Bio-Dot
29 microfiltration apparatus (Bio-Rad). Gentle suction was applied to trap
the detergent and urea-insoluble protein. Membranes were then removed
and washed three times with PBS containing 0.1% SDS, and blocked in PBS
containing 1% Tween-20 with 3% BSA at for at least 2 h room temperature
or overnight at 4°C, then processed in the same manner as for
immunoblotting described above.
Aggregate counting
Cells readied for image-based analysis were plated on glass coverslips then
processed as described in the figure legends. After the allotted time,
coverslips were washed with PBS containing 100 μM CaCl2 and 1 mM
MgCl2 then fixed with 4% paraformaldehyde in PBS. Nuclei were stained
using 1 μg/ml Hoechst 33342 (Life Technologies) for 10 min. After three
washing steps with PBS, the coverslips were mounted using ProLong
Antifade Gold (Life Technologies). The images were acquired using a Leica
SP5 confocal microscope (fields were acquired randomly, and adequate cell
numbers were confirmed by imaging for Hoechst 33342) and counting of
the aggregates was performed using Image J (NIH). For the quantification of
these experiments, a minimum of 100 cells per condition per experiment
were counted.
Statistical analyses, figure creation and software used
One or two-way two-tailed analyses of variance (ANOVA) were performed
unless otherwise noted. All statistical analyses were performed using
Statview 5.0 (SAS Institute, Cary, NC). The respective n-values were
ascertained using power analyses. Adobe Creative Suite 5 (Photoshop and
Illustrator) were used to create all figures, whereas quantification was
performed using ImageJ (NIH).
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